Directory:
Top 10
Directory Statistics
Links: 3017
Categories: 1242
Registered Users: 153
Mailing List Subscribers: 0
Unique Outgoing Hits:
Pagerank Statistics
Tell a Friend
Tell a friend about our website. Fill
out the information below and we will email the recipient
a brief note about our Directory'
Yahoo! News
Web Links [Tag : FDA]
Offers a question and answer about the pharmaceutical companies sponsorship of drug studies. It questions whether information presented is compromised by a profit motive.
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
In order to maintain credibility, several journals are taking steps to require that investigators more clearly reveal the relationships that investigators have with the drug industry.
Receive Health Link via email! Pharmaceutical Company Sponsorship of Drug Studies Q: I just read that several medical journals have concluded that they are changing the criteria by which they accept papers published with research funding supplied by pharmaceutical companies. Does this mean that
Receive Health Link via email! Pharmaceutical Company Sponsorship of Drug Studies Q: I just read that several medical journals have concluded that they are changing the criteria by which they accept papers published with research funding supplied by pharmaceutical companies. Does this mean that
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings 
Google PR
Indian Drug Laws.
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
Health, Pharmaceutical Policies & Reports
mail list of your State Drugs Control Department Officer's for inclusion under Directory Drugs Control Dept.
DrugsControl.org wishes its viewer's a Very Happy Republic Day.
Human Rights aren't just about violence and terrorism. Unsafe drugs too fall into
waiting for hand_moderation
waiting for hand_moderation
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR
Professional information regarding drug use, side effects, interactions and prescribing.
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
Generic Name: Acetazolamide sodium
Acetazolamide Description
Acetazolamide, an inhibitor of the enzyme carbonic anhydrase, is a white to faintly yellowish white crystalline, odorless powder, weakly acidic, very slightly soluble in water and slightly soluble in alcohol. The chemical name for
waiting for hand_moderation
waiting for hand_moderation
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR
Professional information regarding drug use, side effects, interactions and prescribing.
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
Generic Name: acetazolamide
Dosage Form: Extended-Release Capsules
Diamox SEQUELS (Acetazolamide Extended-Release Capsules) are an inhibitor of the enzyme carbonic anhydrase.
Diamox is a white to faintly yellowish white crystalline, odorless powder, weakly acidic, very slightly soluble in water,
waiting for hand_moderation
waiting for hand_moderation
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR
US Food and Drug Administration study seems to confirm suspicions that antidepressant drugs may increase the risk of suicidal behavior in children and teens. Study re-examined nine different antidepressants, finding that young people were more likely to harm themselves on these drugs than on placebos. [3:39 streaming audio broadcast]
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
A Food and Drug Administration study seems to confirm suspicions that antidepressant drugs may increase the risk of suicidal behavior in children and teens. The FDA re-examined nine different antidepressants. It found that young people given the drugs were more likely to harm themselves than those who took placebos. NPR's David Baron reports.
| Share this page using one of the following services: FDA Study Links Antidepressants, Teen Suicide , August 20, 2004 · The Food and Drug Administration releases a long-awaited analysis of the possible risks posed by antidepressants to children and teens. The study comes on the heels of a
| Share this page using one of the following services: FDA Study Links Antidepressants, Teen Suicide , August 20, 2004 · The Food and Drug Administration releases a long-awaited analysis of the possible risks posed by antidepressants to children and teens. The study comes on the heels of a
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR 6. BiDil
Listing for FDA approved drug therapies archives from CenterWatch. (isosorbide dinitrate/hydralazine hydrochloride)
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
Organized by therapeutic area, this comprehensive listing of recently approved drugs by the Food and Drug Administration features facts on clinical trial results, side effects and other general information. Find out more about the types of drugs included in this listing. Listing for BiDil (isosorbide dinitrate/hydralazine hydrochloride) in FDA Approved Drug Therapies Archives from CenterWatch Clinical Trials Listing Service
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients. The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: BiDil (isosorbide
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients. The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: BiDil (isosorbide
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR
Describes the trial results and subsequent approval of Tracleer.
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
FDA Approves First Oral Medication for Pulmonary Arterial Hypertension
FDA Talk Papers are prepared by the Press Office to guide FDA personnel in responding with consistency and accuracy to questions from the public on subjects of current interest. Talk Papers are subject to change as more information becomes available. Print Media: 301-827-6242 Consumer
FDA Talk Papers are prepared by the Press Office to guide FDA personnel in responding with consistency and accuracy to questions from the public on subjects of current interest. Talk Papers are subject to change as more information becomes available. Print Media: 301-827-6242 Consumer
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR 8. Xeloda
Features product details for US consumers and healthcare professionals as well as information about breast and colorectal cancer. [Requires Flash]
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
Patient Support Program to get expert advice from oncology nurses and personalized updated e-mails throughout your treatment.
easy ways to work with your healthcare team that will help you effectively monitor and report side effects.
a list of questions for your next doctor visit. (in pdf format)
waiting for hand_moderation
waiting for hand_moderation
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR
Listing for Cancidas in FDA Approved Drug Therapies Archives with brief summary for patients.
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
Organized by therapeutic area, this comprehensive listing of recently approved drugs by the Food and Drug Administration features facts on clinical trial results, side effects and other general information. Find out more about the types of drugs included in this listing. Listing for Cancidas in FDA Approved Drug Therapies Archives from CenterWatch Clinical Trials Listing Service
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients. The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Approval Status: Approved
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients. The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Approval Status: Approved
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR
Notification of important changes in the U.S. FDA Propulsid labeling to reflect new safety information, including recommendations for performing diagnostics tests prior to any use.
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Category:
Random Site Quote:
DESCRIBE CONTENTS
FDA posts safety alerts, public health advisories, press releases and other notices from companies as a service to health professionals, consumers and other interested parties. Although FDA approves medical products, FDA does not endorse either the product or the company. This is the retyped text
FDA posts safety alerts, public health advisories, press releases and other notices from companies as a service to health professionals, consumers and other interested parties. Although FDA approves medical products, FDA does not endorse either the product or the company. This is the retyped text
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
Member Reviews
Visitor Ratings Google PR